Antihypertensive Treatment of Acute Cerebral Hemorrhage-II

A phase 3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 1000 participants.

Also called NCT01176565

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 1,000 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01176565
Other papers using this trial's data
  • Blood pressure reduction and noncontrast CT markers of intracerebral hemorrhage expansion Neurology, 2017-08-08 DOI, PubMed 28701501, PMC5562954 Not in the PMC Open Access subset.
  • Cerebral Microbleeds and the Effect of Intensive Blood Pressure Reduction on Hematoma Expansion and Functional Outcomes: A Secondary Analysis of the ATACH-2 Randomized Clinical Trial JAMA neurology, 2018-07-01 DOI, PubMed 29710119, PMC6145762 Not in the PMC Open Access subset.
  • Clinical Outcomes Depending on Acute Blood Pressure After Cerebral Hemorrhage Annals of neurology, 2019-01 DOI, PubMed 30421455
  • Effect of Moderate and Severe Persistent Hyperglycemia on Outcomes in Patients With Intracerebral Hemorrhage Stroke, 2022-04 DOI, PubMed 34844422
  • Hematoma Expansion Shift Analysis to Assess Acute Intracerebral Hemorrhage Treatments Neurology, 2021-08-24 DOI, PubMed 34144995
  • Impact of Renal Impairment on Intensive Blood-Pressure-Lowering Therapy and Outcomes in Intracerebral Hemorrhage: Results From ATACH-2 Neurology, 2021-08-31 DOI, PubMed 34210824, PMC8408509 In the PMC Open Access subset under CC BY-NC-ND.
  • Intensive Blood Pressure Lowering and DWI Lesions in Intracerebral Hemorrhage: Exploratory Analysis of the ATACH-2 Randomized Trial Neurocritical care, 2022-02 DOI, PubMed 34292474
  • Intensive Blood Pressure Lowering in Patients with Moderate to Severe Grade Acute Cerebral Hemorrhage: Post Hoc Analysis of Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH)-2 Trial Cerebrovascular diseases (Basel, Switzerland), 2020 DOI, PubMed 32585668
  • Intensive Blood Pressure Reduction and Spot Sign in Intracerebral Hemorrhage: A Secondary Analysis of a Randomized Clinical Trial JAMA neurology, 2017-08-01 DOI, PubMed 28628707, PMC5584592 Not in the PMC Open Access subset.
  • Intensive Blood-Pressure Lowering in Patients with Acute Cerebral Hemorrhage The New England journal of medicine, 2016-09-15 DOI, PubMed 27276234, PMC5345109 In the PMC Open Access subset under a licence that is not Creative Commons.
  • Optimal Magnitude of Blood Pressure Reduction and Hematoma Growth and Functional Outcomes in Intracerebral Hemorrhage Neurology, 2025-03-11 DOI, PubMed 39913881, PMC11803522 Not in the PMC Open Access subset.
  • Regional Differences in the Response to Acute Blood Pressure Lowering After Cerebral Hemorrhage Neurology, 2021-02-02 DOI, PubMed 33219136, PMC7884997 In the PMC Open Access subset under CC BY-NC-ND.
  • Sex Differences in Blood Pressure-Lowering Therapy and Outcomes Following Intracerebral Hemorrhage: Results From ATACH-2 Stroke, 2020-08 DOI, PubMed 32623977, PMC9371624 In the PMC Open Access subset under a licence that is not Creative Commons.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Canada, China, Germany, Japan, South Korea, Taiwan (from the registry)
Registry status
  • Terminated (from the registry)

Technical summary

Registry record NCT01176565. Randomized; double masking; primary purpose treatment. Start 2011-05-15 (actual); primary completion 2015-12-21 (actual). Results posted on 2017-04-25.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Antihypertensive Treatment of Acute Cerebral Hemorrhage-II
Acronym
ATACH-II
Condition
Intracerebral Hemorrhage
Intervention (Drug)
Intravenous nicardipine hydrochloride
Lead sponsor
University of Minnesota (class: other)
Collaborator
National Institute of Neurological Disorders and Stroke (NINDS) (class: US National Institutes of Health)
Collaborator
Medical University of South Carolina (class: other)
Collaborator
Johns Hopkins University (class: other)
Collaborator
University of Michigan (class: other)
Collaborator
Neurocritical Care Research Network (class: not stated)
Collaborator
National Cerebral and Cardiovascular Center, Japan (class: other)
Collaborator
Japan Cardiovascular Research Foundation (class: other)
Collaborator
Beijing Tiantan Hospital (class: other)
Collaborator
China Medical University Hospital (class: other)
Collaborator
University Hospital Heidelberg (class: other)
Collaborator
Seoul National University Hospital (class: other)

Record details

Record id
cardio:ct-nct01176565
Content hash
bd2a727a6cedcfe04533197891079fbea2ef3f92cffa1203f5540fc3097d4925